Composite Interceptive Med-Science Laboratories Private Limited, a active private limited company, was established on 05 January 2018 in Bengaluru, Karnataka, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U73100KA2018PTC109264. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.10 Cr and a paid-up capital of ₹2.07 Cr.
Employing 3 professional, Its leadership includes Paul Christadas Salins (Director), Samarth Shetty (Director). Past directors included Mukesh Kumar Chauhan, Vikash, William Nanda Bissell. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Pragati Plaza, Opp Biocon Housur Main Road, Hebbagodi, Bengaluru, Karnataka, 560099.
U73100KA2018PTC109264
109264
05 January 2018
₹5.10 Cr
₹2.07 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Composite Interceptive Med-Science Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paul Christadas Salins | Director | 05 Jan 2018 | Current |
| Samarth Shetty | Director | 25 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Oct 2019 | Past |
| Pramod Abcsdd | Additional Director | 04 Apr 2020 | Past |
| Pramod Abcsdd | Director | 20 Feb 2019 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Composite Interceptive Med-Science Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Composite Interceptive Med-Science Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Composite Interceptive Med-Science Laboratories has a workforce of 3 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Composite Interceptive Med-Science Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Composite Interceptive Med-Science Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Samarth Shetty was appointed as a Director was appointed as a Director on 25 Aug 2025 & has been associated with this company since 4 months 8 days . was recorded as a recent event.
Composite Interceptive Med-Science Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Composite Interceptive Med-Science Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Paul Christadas Salins was appointed as a Director was appointed as a Director on 05 Jan 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
The activity Composite Interceptive Med-Science Laboratories Private Limited was registered on 05 Jan 2018 with Roc Bangalore & aged 7 years 11 months as per MCA records. was completed.
The CIN of Composite Interceptive Med-Science Laboratories Private Limited is U73100KA2018PTC109264.
Composite Interceptive Med-Science Laboratories Private Limited is headquartered at 2Nd Floor, Pragati Plaza, Opp Biocon Housur Main Road, Hebbagodi, Bengaluru, Karnataka, 560099.
Composite Interceptive Med-Science Laboratories Private Limited was incorporated on 05 January 2018.
The current directors of Composite Interceptive Med-Science Laboratories Private Limited are
The primary industry of Composite Interceptive Med-Science Laboratories Private Limited is Healthcare.
Composite Interceptive Med-Science Laboratories Private Limited is unlisted.
The authorized capital of Composite Interceptive Med-Science Laboratories Private Limited is ₹5.10 Cr, and the paid-up capital is ₹2.07 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX